Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2013 1
2018 1
2019 3
2020 5
2021 7
2022 6
2023 12
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Results by year

Filters applied: . Clear all
Page 1
Sodium-glucose co-transporter 2 inhibitors and hematopoiesis.
Yaribeygi H, Maleki M, Nasimi F, Butler AE, Jamialahmadi T, Sahebkar A. Yaribeygi H, et al. Among authors: maleki m. J Cell Physiol. 2022 Oct;237(10):3778-3787. doi: 10.1002/jcp.30851. Epub 2022 Aug 11. J Cell Physiol. 2022. PMID: 35951776 Review.
SGLT2 inhibitors and autophagy in diabetes.
Yaribeygi H, Maleki M, Atkin SL, Jamialahmadi T, Sahebkar A. Yaribeygi H, et al. Among authors: maleki m. Cell Biochem Funct. 2023 Jun;41(4):392-398. doi: 10.1002/cbf.3792. Epub 2023 Apr 10. Cell Biochem Funct. 2023. PMID: 37036046 Review.
Sodium-glucose co-transporter-2 inhibitors and epicardial adiposity.
Yaribeygi H, Maleki M, Butler AE, Jamialahmadi T, Sahebkar A. Yaribeygi H, et al. Among authors: maleki m. Eur J Pharm Sci. 2023 Jan 1;180:106322. doi: 10.1016/j.ejps.2022.106322. Epub 2022 Nov 3. Eur J Pharm Sci. 2023. PMID: 36336279 Free article. Review.
Molecular mechanisms linking stress and insulin resistance.
Yaribeygi H, Maleki M, Butler AE, Jamialahmadi T, Sahebkar A. Yaribeygi H, et al. Among authors: maleki m. EXCLI J. 2022 Jan 24;21:317-334. doi: 10.17179/excli2021-4382. eCollection 2022. EXCLI J. 2022. PMID: 35368460 Free PMC article. Review.
Brain insulin signaling and cognition: Possible links.
Yaribeygi H, Maleki M, Butler AE, Jamialahmadi T, Sahebkar A. Yaribeygi H, et al. Among authors: maleki m. EXCLI J. 2023 Feb 13;22:237-249. doi: 10.17179/excli2023-5841. eCollection 2023. EXCLI J. 2023. PMID: 36998706 Free PMC article. Review.
Renoprotective Roles of Curcumin.
Yaribeygi H, Maleki M, Majeed M, Jamialahmadi T, Sahebkar A. Yaribeygi H, et al. Among authors: maleki m. Adv Exp Med Biol. 2021;1328:531-544. doi: 10.1007/978-3-030-73234-9_38. Adv Exp Med Biol. 2021. PMID: 34981504
Impact of Incretin-Based Therapies on Adipokines and Adiponectin.
Yaribeygi H, Maleki M, Atkin SL, Jamialahmadi T, Sahebkar A. Yaribeygi H, et al. Among authors: maleki m. J Diabetes Res. 2021 Oct 7;2021:3331865. doi: 10.1155/2021/3331865. eCollection 2021. J Diabetes Res. 2021. PMID: 34660808 Free PMC article. Review.
Molecular Mechanisms by Which Imeglimin Improves Glucose Homeostasis.
Yaribeygi H, Maleki M, Sathyapalan T, Jamialahmadi T, Sahebkar A. Yaribeygi H, et al. Among authors: maleki m. J Diabetes Res. 2020 Mar 6;2020:8768954. doi: 10.1155/2020/8768954. eCollection 2020. J Diabetes Res. 2020. PMID: 32215274 Free PMC article. Review.
Nanoparticles with SGLT2 inhibitory activity: Possible benefits and future.
Yaribeygi H, Maleki M, Jamialahmadi T, Shakhpazyan NK, Kesharwani P, Sahebkar A. Yaribeygi H, et al. Among authors: maleki m. Diabetes Metab Syndr. 2023 Oct;17(10):102869. doi: 10.1016/j.dsx.2023.102869. Epub 2023 Sep 25. Diabetes Metab Syndr. 2023. PMID: 37778134 Review.
37 results